Fortnite’s 35.10 update is set to introduce new weapons as well as other exciting additions in Chapter 6, Season 3.

Think you’ve got the rarest Fortnite pickaxe? Unless it’s truly vaulted, you’re just swinging recycled pixels.

April 30, 2025 – The FDA has approved a new cell-based gene therapy for people with a rare genetic skin disorder known as recessive dystrophic epidermolysis bullosa (RDEB) after clinical ...

The U.S. Food and Drug Administration has approved Abeona Therapeutics' Zevaskyn (prademagene zamikeracel) for patients with the rare, genetic skin disorder recessive dystrophic epidermolysis bullosa.

The Food and Drug Administration on Tuesday approved a new treatment for a rare skin condition, teeing up a commercial battle between two cell and gene therapy developers. The agency cleared ...

April 29 (Reuters) - The U.S. Food and Drug Administration approved Abeona Therapeutics' (ABEO.O), opens new tab gene therapy for a rare skin disorder on Tuesday. The gene therapy, called Zevaskyn ...

TUESDAY, April 29, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Zevaskyn (prademagene zamikeracel) for patients with the rare, genetic skin disorder recessive ...

Barely a year after the U.S. FDA shackled Abeona Therapeutics Inc.’s cell-based gene therapy with a complete response letter, the agency has approved it for treating a rare and genetic skin disease.